Evidence map›Paper›PMID 20471366›Full record

ArticleBiochemical and biophysical research communications2010

Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX.

Michael J Shapiro, Lynn Spruce, Rhianna Sundsbak, Puspa Thapa, Virginia Smith Shapiro

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael J ShapiroDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Lynn Spruce
Rhianna Sundsbak
Puspa Thapa
Virginia Smith Shapiro
Mayo Clinic · USChildren's Hospital of Philadelphia · USWinnMed · US

Funding

Role of ALX in CD28 signalingR01AI054974 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHAPIRO, VIRGINIA SMITH · 2004 to 2008
$1.7M
NIAID NIH HHS R01 AI054974
6 · The paper itself

Abstract

The activation of T cells and the initiation of an immune response is tightly controlled by both positive and negative regulators. Two adaptors which function as negative regulators of T cell activation are ALX and LAX. ALX constitutively associates with LAX in T cells, and T cells from mice deficient in ALX and LAX display similar hyper-responsiveness upon T cell receptor (TCR)/CD28 stimulation, including increased production of interleukin-2. During T cell activation, ALX is inducibly phosphorylated, however the site of ALX phosphorylation had not been previously identified and the role of phosphorylation in the inhibitory function of ALX was not known. Here, using mass spectrometry, we demonstrate that ALX is phosphorylated on a serine at position 318. Substitution of alanine for serine at this position (ALX S318A) leads to an abrogation of the mobility shift in ALX induced upon TCR/CD28 stimulation. However, ALX S318A retained the ability to bind to and stimulate tyrosine phosphorylation of LAX. In addition, overexpression of ALX S318A inhibited RE/AP activation upon TCR/CD28 stimulation to a similar extent as wild-type ALX. Therefore, although ALX is inducibly phosphorylated upon TCR/CD28 stimulation, this phosphorylation is not required for ALX to inhibit T cell activation.

Indexed as

Lymphocyte ActivationAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAmino Acid SequenceAnimalsCD28 AntigensHumansJurkat CellsMass SpectrometryMicePhosphorylationReceptors, Antigen, T-CellSerineT-LymphocytesAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportCD28 AntigensHSH2D protein, humanLAX1 protein, humanReceptors, Antigen, T-CellSerine

Identifiers

PMID20471366
PMCPMC2897073
OpenAlexW2106119498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.